Most Popular White Papers
Shareholder Alert for Threshold Pharmaceuticals Inc.
M2 Presswire, January, 2007
 | Content provided in partnership with |  |
M2 PRESSWIRE-4 January 2007-Biotech News: Shareholder Alert for Threshold Pharmaceuticals Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:04012007 By targeting differences in the metabolism of normal and diseased cells, Threshold Pharmaceticals (NASDAQ:THLD) hopes to develop drugs that are less toxic to healthy tissues.
The biotechnology company focuses on discovering and developing therapeutics based on its Metabolic Targeting system. The company's leading product candidate is glufosfamide, which could treat pancreatic cancer. Another product, TH-070, could treat benign prostatic ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Business
- Academy of Marketing Science Review
- Accounting Historians Journal, The
- Accounting History
- AgExporter
- Agricultural Research
- Agricultural and Resource Economics Review
- Air Force Comptroller
- Air Safety Week
- Airline Industry Information
- American Demographics
- American Journal of Potato Research
- Architectural Review, The
- Asian Economic News
- Entrepreneur